NRSE 6230 (NRSE 6230)

Module 2 Chapters 11 to 27 complete questions with correct answers Last document update:   ago

Chapter 11: Contact Dermatitis 1. What is dermatitis? 2. What are the causes of contact dermatitis? 3. What is the pharmacogenomics for dermatitis? 4. What is the diagnostic criteria for dermatitis? 5. When do you initiate drug therapy for dermatitis? 6. What are the goals of therapy? 7. What are the treatments for dermatitis? a. Table 11.1 on page 157 b. Topical corticosteroids- safer than systemic steroidal therapies. i. Dosage- intermediate or high-potency topical corticostero...

Module 2 Chapters 11 to 27 complete notes Last document update:   ago

Chapter 11: Contact Dermatitis 1. What is dermatitis? 2. What are the causes of contact dermatitis? 3. What is the pharmacogenomics for dermatitis? 4. What is the diagnostic criteria for dermatitis? 5. When do you initiate drug therapy for dermatitis? 6. What are the goals of therapy? 7. What are the treatments for dermatitis? a. Table 11.1 on page 157 b. Topical corticosteroids- safer than systemic steroidal therapies. i. Dosage- intermediate or high-potency topical corticostero...

Module 2 Chapter 11 t0 27 complete notes Last document update:   ago

Chapter 11: Contact Dermatitis 1. What is dermatitis? 2. What are the causes of contact dermatitis? 3. What is the pharmacogenomics for dermatitis? 4. What is the diagnostic criteria for dermatitis? 5. When do you initiate drug therapy for dermatitis? 6. What are the goals of therapy? 7. What are the treatments for dermatitis? a. Table 11.1 on page 157 b. Topical corticosteroids- safer than systemic steroidal therapies. i. Dosage- intermediate or high-potency topical corticostero...